• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜异位症女性子宫内膜组织特异性补体激活的评估。

Evaluation of endometrial tissue specific complement activation in women with endometriosis.

作者信息

D'Cruz O J, Wild R A

机构信息

Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City.

出版信息

Fertil Steril. 1992 Apr;57(4):787-95.

PMID:1372870
Abstract

OBJECTIVE

To determine if endometrial tissue specific complement (C) activation occurs in patients with endometriosis.

DESIGN

Prospective.

SETTING

University of Oklahoma Health Sciences Center, a tertiary care referral center.

PATIENTS

Twenty-six women, 9 with endometriosis and 17 without endometriosis.

INTERVENTIONS

None.

MAIN OUTCOME MEASURES

Uterine and ectopic endometria were evaluated by the immunofluorescence assay for the presence of activated products of the initial (C3d) and terminal (C5b-9) C pathway, C3 regulatory proteins (decay-accelerating factor and membrane cofactor protein), and terminal C regulatory proteins (clusterin and vitronectin).

RESULTS

The initial (C3d) and terminal (C5b-9) C components were deposited on blood vessel walls in uterine and/or ectopic endometria of women with and without endometriosis. In the stromal compartment at both sites, C deposition was colocalized with terminal C inhibitors/cell-cell attachment factors, clusterin and vitronectin on elastic fibers. No specific staining for C proteins was detected on the glandular epithelium of uterine and ectopic endometrial tissues examined. Furthermore, intense staining of endometrial epithelium for C3 regulatory proteins, decay-accelerating factor, and membrane cofactor protein was noted on endometrial glands from women with and without endometriosis.

CONCLUSIONS

Our findings demonstrate a lack of specific deposition of C in the glandular epithelial cells of endometria of women with endometriosis. The localization of C3 regulatory proteins, decay-accelerating factor, and membrane cofactor protein on glandular epithelium may suggest the involvement of intrinsic protective mechanisms on these cells from autologous C attack in vivo.

摘要

目的

确定子宫内膜异位症患者是否发生子宫内膜组织特异性补体(C)激活。

设计

前瞻性研究。

地点

俄克拉荷马大学健康科学中心,一家三级医疗转诊中心。

患者

26名女性,9名患有子宫内膜异位症,17名未患子宫内膜异位症。

干预措施

无。

主要观察指标

通过免疫荧光测定法评估子宫和异位子宫内膜中补体初始途径(C3d)和终末途径(C5b - 9)的激活产物、C3调节蛋白(衰变加速因子和膜辅因子蛋白)以及终末补体调节蛋白(簇集素和玻连蛋白)的存在情况。

结果

补体初始成分(C3d)和终末成分(C5b - 9)沉积在患有和未患子宫内膜异位症女性的子宫和/或异位子宫内膜的血管壁上。在两个部位的间质区,补体沉积与终末补体抑制剂/细胞间黏附因子、弹性纤维上的簇集素和玻连蛋白共定位。在所检查的子宫和异位子宫内膜组织的腺上皮上未检测到补体蛋白的特异性染色。此外,在患有和未患子宫内膜异位症女性的子宫内膜腺体上均观察到补体C3调节蛋白、衰变加速因子和膜辅因子蛋白的强烈染色。

结论

我们的研究结果表明,子宫内膜异位症女性的子宫内膜腺上皮细胞中缺乏补体的特异性沉积。补体C3调节蛋白、衰变加速因子和膜辅因子蛋白在腺上皮上的定位可能提示这些细胞存在内在保护机制以防止体内自身补体的攻击。

相似文献

1
Evaluation of endometrial tissue specific complement activation in women with endometriosis.子宫内膜异位症女性子宫内膜组织特异性补体激活的评估。
Fertil Steril. 1992 Apr;57(4):787-95.
2
The endometria of women with endometriosis exhibit dysfunctional expression of complement regulatory proteins during the mid secretory phase.子宫内膜异位症患者的子宫内膜在分泌中期表现出补体调节蛋白的功能失调表达。
J Reprod Immunol. 2018 Feb;125:1-7. doi: 10.1016/j.jri.2017.10.046. Epub 2017 Oct 27.
3
Hormonal regulation of complement components and receptors throughout the menstrual cycle.整个月经周期中补体成分和受体的激素调节。
Am J Obstet Gynecol. 1994 Jan;170(1 Pt 1):168-75. doi: 10.1016/s0002-9378(94)70404-x.
4
Protection of thyroid cancer cells by complement-regulatory factors.补体调节因子对甲状腺癌细胞的保护作用。
Cancer. 1994 Jun 1;73(11):2808-17. doi: 10.1002/1097-0142(19940601)73:11<2808::aid-cncr2820731125>3.0.co;2-p.
5
Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy.糖尿病视网膜病变患者眼部脉络膜毛细血管中存在大量补体C3d和C5b-9沉积。
Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1104-8.
6
Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).人类癌症会不同程度地表达补体抑制蛋白CD46(膜辅因子蛋白)、CD55(衰变加速因子)和CD59(保护素)。
Am J Pathol. 1996 Jul;149(1):129-42.
7
HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium.HLA-G在腹膜子宫内膜异位症的腺上皮中表达,但在位内膜中不表达。
Hum Reprod. 2006 Apr;21(4):864-9. doi: 10.1093/humrep/dei408. Epub 2005 Nov 25.
8
Expression of complement regulating factors in gastric cancer cells.胃癌细胞中补体调节因子的表达
Mol Pathol. 2002 Jun;55(3):193-9. doi: 10.1136/mp.55.3.193.
9
Epithelial localization of antiendometrial antibodies associated with endometriosis.与子宫内膜异位症相关的抗子宫内膜抗体的上皮定位
Am J Reprod Immunol Microbiol. 1987 Feb;13(2):62-5. doi: 10.1111/j.1600-0897.1987.tb00092.x.
10
Production and secretion of complement component 3 by endometriotic tissue.
J Clin Endocrinol Metab. 1989 Nov;69(5):1003-9. doi: 10.1210/jcem-69-5-1003.

引用本文的文献

1
Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target.子宫内膜异位症的免疫学基础:补体系统作为潜在的治疗靶点。
Front Immunol. 2021 Jan 11;11:599117. doi: 10.3389/fimmu.2020.599117. eCollection 2020.